US Patent Issued to Institut Gustave-Roussy, Transgene on May 12 for "Combination of oncolytic virus with immune checkpoint modulators" (French Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,937, issued on May 12, was assigned to Institut Gustave-Roussy (Villejuif, France) and Transgene SA (Illkirch Graffenstaden, France).

"Combination of oncolytic virus with immune checkpoint modulators" was invented by Laurence Zitvogel (Paris), Xavier Preville (Saint Louis, France) and Laetitia Fend (Le Kremlin-bicetre, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a combination comprising at least an oncolytic virus and one or more immune check-point modulator(s) for use for the treatment of a proliferative disease such as cancer. It also relates to a kit comprising said oncolytic virus and said one or more immu...